Floatz logo

Mazdutide

Hypertensive

Innovent Biologics (Suzhou) Co. Ltd.protein_peptidePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

33 Active assets in the Hypertensive cohort.

Asset / SponsorPhaseRating
Hydrochlorothiazide
University of Kansas Medical Center
Phase 4BBB
VALSARTAN
University of Alabama at Birmingham
Phase 4BBB
Losartan
Rong Zhang
Phase 4BBB
AMLODIPINE
Jing Liu
Phase 4BBB
Trandolapril
University of Florida
Phase 4BBB

View all 50 →

Same molecule, other indications

Mazdutide is also rated in:

obesity disorderDormant
BB
Indicative ·
70 / 100
View asset →
coronary artery disorderDormant
BB
Indicative ·
65 / 100
View asset →
sleep apnea syndromeDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →